Shares of ProMIS Neurosciences, Inc. (TSE:PMN – Get Free Report) dropped 3.8% during mid-day trading on Monday . The company traded as low as C$5.98 and last traded at C$6.00. Approximately 19,701 shares were traded during mid-day trading, an increase of 492% from the average daily volume of 3,327 shares. The stock had previously closed at C$6.24.
ProMIS Neurosciences Stock Down 3.8 %
The stock has a market capitalization of C$51.48 million, a P/E ratio of -1.78 and a beta of 1.19. The company has a debt-to-equity ratio of 108.33, a quick ratio of 1.30 and a current ratio of 0.51. The firm has a fifty day simple moving average of C$6.00.
About ProMIS Neurosciences
ProMIS Neurosciences, Inc discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins.
Featured Articles
- Five stocks we like better than ProMIS Neurosciences
- Industrial Products Stocks Investing
- 3 Momentum Trades for October With Ample Upside Ahead
- Business Services Stocks Investing
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- Investing In Automotive Stocks
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for ProMIS Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMIS Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.